618 related articles for article (PubMed ID: 20675495)
1. Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production.
Merrigan M; Venugopal A; Mallozzi M; Roxas B; Viswanathan VK; Johnson S; Gerding DN; Vedantam G
J Bacteriol; 2010 Oct; 192(19):4904-11. PubMed ID: 20675495
[TBL] [Abstract][Full Text] [Related]
2. TcdC does not significantly repress toxin expression in Clostridium difficile 630ΔErm.
Bakker D; Smits WK; Kuijper EJ; Corver J
PLoS One; 2012; 7(8):e43247. PubMed ID: 22912837
[TBL] [Abstract][Full Text] [Related]
3. Truncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin A.
Murray R; Boyd D; Levett PN; Mulvey MR; Alfa MJ
BMC Infect Dis; 2009 Jun; 9():103. PubMed ID: 19558711
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of BI/NAP1/027 hypervirulent strains reveals novel toxin B-encoding gene (tcdB) sequences.
Stabler RA; Dawson LF; Phua LTH; Wren BW
J Med Microbiol; 2008 Jun; 57(Pt 6):771-775. PubMed ID: 18480336
[TBL] [Abstract][Full Text] [Related]
5. Clostridium difficile toxin synthesis is negatively regulated by TcdC.
Dupuy B; Govind R; Antunes A; Matamouros S
J Med Microbiol; 2008 Jun; 57(Pt 6):685-689. PubMed ID: 18480323
[TBL] [Abstract][Full Text] [Related]
6. RstA Is a Major Regulator of Clostridioides difficile Toxin Production and Motility.
Edwards AN; Anjuwon-Foster BR; McBride SM
mBio; 2019 Mar; 10(2):. PubMed ID: 30862746
[No Abstract] [Full Text] [Related]
7. Lack of association between clinical outcome of Clostridium difficile infections, strain type, and virulence-associated phenotypes.
Sirard S; Valiquette L; Fortier LC
J Clin Microbiol; 2011 Dec; 49(12):4040-6. PubMed ID: 21956985
[TBL] [Abstract][Full Text] [Related]
8. Combined and Distinct Roles of Agr Proteins in Clostridioides difficile 630 Sporulation, Motility, and Toxin Production.
Ahmed UKB; Shadid TM; Larabee JL; Ballard JD
mBio; 2020 Dec; 11(6):. PubMed ID: 33443122
[TBL] [Abstract][Full Text] [Related]
9. Mathematical modelling reveals properties of TcdC required for it to be a negative regulator of toxin production in Clostridium difficile.
Jabbari S; Cartman ST; King JR
J Math Biol; 2015 Mar; 70(4):773-804. PubMed ID: 24687436
[TBL] [Abstract][Full Text] [Related]
10. Clostridium difficile toxin expression is inhibited by the novel regulator TcdC.
Matamouros S; England P; Dupuy B
Mol Microbiol; 2007 Jun; 64(5):1274-88. PubMed ID: 17542920
[TBL] [Abstract][Full Text] [Related]
11. The second messenger cyclic Di-GMP regulates Clostridium difficile toxin production by controlling expression of sigD.
McKee RW; Mangalea MR; Purcell EB; Borchardt EK; Tamayo R
J Bacteriol; 2013 Nov; 195(22):5174-85. PubMed ID: 24039264
[TBL] [Abstract][Full Text] [Related]
12. Strain-Dependent RstA Regulation of Clostridioides difficile Toxin Production and Sporulation.
Edwards AN; Krall EG; McBride SM
J Bacteriol; 2020 Jan; 202(2):. PubMed ID: 31659010
[TBL] [Abstract][Full Text] [Related]
13. Study of the frequency of Clostridium difficile tcdA, tcdB, cdtA and cdtB genes in feces of Calves in south west of Iran.
Doosti A; Mokhtari-Farsani A
Ann Clin Microbiol Antimicrob; 2014 Jun; 13():21. PubMed ID: 24903619
[TBL] [Abstract][Full Text] [Related]
14. The C-Terminal Domain of Clostridioides difficile TcdC Is Exposed on the Bacterial Cell Surface.
Oliveira Paiva AM; de Jong L; Friggen AH; Smits WK; Corver J
J Bacteriol; 2020 Oct; 202(22):. PubMed ID: 32868401
[No Abstract] [Full Text] [Related]
15. Comparison of toxin and spore production in clinically relevant strains of Clostridium difficile.
Vohra P; Poxton IR
Microbiology (Reading); 2011 May; 157(Pt 5):1343-1353. PubMed ID: 21330434
[TBL] [Abstract][Full Text] [Related]
16. The key sigma factor of transition phase, SigH, controls sporulation, metabolism, and virulence factor expression in Clostridium difficile.
Saujet L; Monot M; Dupuy B; Soutourina O; Martin-Verstraete I
J Bacteriol; 2011 Jul; 193(13):3186-96. PubMed ID: 21572003
[TBL] [Abstract][Full Text] [Related]
17. Sequence variation in tcdA and tcdB of Clostridium difficile: ST37 with truncated tcdA is a potential epidemic strain in China.
Du P; Cao B; Wang J; Li W; Jia H; Zhang W; Lu J; Li Z; Yu H; Chen C; Cheng Y
J Clin Microbiol; 2014 Sep; 52(9):3264-70. PubMed ID: 24958798
[TBL] [Abstract][Full Text] [Related]
18. The anti-sigma factor TcdC modulates hypervirulence in an epidemic BI/NAP1/027 clinical isolate of Clostridium difficile.
Carter GP; Douce GR; Govind R; Howarth PM; Mackin KE; Spencer J; Buckley AM; Antunes A; Kotsanas D; Jenkin GA; Dupuy B; Rood JI; Lyras D
PLoS Pathog; 2011 Oct; 7(10):e1002317. PubMed ID: 22022270
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the SigD regulon of C. difficile and its positive control of toxin production through the regulation of tcdR.
El Meouche I; Peltier J; Monot M; Soutourina O; Pestel-Caron M; Dupuy B; Pons JL
PLoS One; 2013; 8(12):e83748. PubMed ID: 24358307
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates.
Spigaglia P; Mastrantonio P
J Clin Microbiol; 2002 Sep; 40(9):3470-5. PubMed ID: 12202595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
